Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion

Nutrition Research

Volumn 34, Issue 10, 2014, Pages 876-885

  Tsubouchi, Hironobu ^a   Yanagi, Shigehisa ^a   Miura, Ayako ^a   Mogami, Sachiko ^b   Yamada, Chihiro ^b   Iizuka, Seiichi ^b   Hattori, Tomohisa ^b   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Bleomycin; Cachexia; Ghrelin; Lung fibrosis; Mice; Rikkunshito

Indexed keywords

ATROGIN 1; BLEOMYCIN; GHRELIN; GHRELIN RECEPTOR; KAMPO; MUSCLE RING FINGER 1 PROTEIN; RIKKUNSHITO; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; WATER; FBXO32 PROTEIN, RAT; HERBACEOUS AGENT; LIU-JUN-ZI-TANG; MUSCLE PROTEIN; TRIM63 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRACTYLODES; AURANTIMONAS; BLOOD LEVEL; BODY WEIGHT; CACHEXIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FOOD INTAKE; GINGER; GINSENG; GLYCYRRHIZA; HORMONE RELEASE; LUNG FIBROSIS; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PINELLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TREATMENT OUTCOME; WEIGHT REDUCTION; ZIZIPHUS; ANIMAL; C57BL MOUSE; CALORIC INTAKE; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; EATING; METABOLISM; MUSCULAR ATROPHY; PATHOLOGY; PHYTOTHERAPY; SECRETION (PROCESS);

MUS;

ANIMALS; BLEOMYCIN; CACHEXIA; DRUGS, CHINESE HERBAL; EATING; ENERGY INTAKE; GHRELIN; MALE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PHYTOTHERAPY; PULMONARY FIBROSIS; RECEPTORS, GHRELIN; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASES; WEIGHT LOSS;

EID: 84927691678     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.08.014     Document Type: Article

References (39)

1. Fearon K.C., Glass D.J., Guttridge D.C. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012, 16:153-166.
2. Remels A.H., Gosker H.R., Langen R.C., Schols A.M. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol 2013, 114:1253-1262.
3. Nishimura K., Izumi T., Tsukino M., Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002, 121:1434-1440.
4. Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Kato K., Kataoka K., et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J 2010, 36:1067-1072.
5. Fitting J.W., Frascarolo P., Jequier E., Leuenberger P. Resting energy expenditure in interstitial lung disease. Am Rev Respir Dis 1990, 142:631-635.
6. Ramires B.R., de Oliveira E.P., Pimentel G.D., McLellan K.C., Nakato D.M., Faganello M.M., et al. Resting energy expenditure and carbohydrate oxidation are higher in elderly patients with COPD: a case control study. Nutr J 2012, 11:37.
7. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
8. Alakhras M., Decker P.A., Nadrous H.F., Collazo-Clavell M., Ryu J.H. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest 2007, 131:1448-1453.
9. Cano N.J., Pichard C., Roth H., Court-Fortune I., Cynober L., Gerard-Boncompain M., et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 2004, 126:540-546.
10. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
11. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
12. Porporato P.E., Filigheddu N., Reano S., Ferrara M., Angelino E., Gnocchi V.F., et al. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest 2013, 123:611-622.
13. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005, 128:1187-1193.
14. Yagi M., Homma S., Kubota M., Iinuma Y., Kanada S., Kinoshita Y., et al. The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery. Pediatr Surg Int 2004, 19:760-765.
15. Arai M., Matsumura T., Tsuchiya N., Sadakane C., Inami R., Suzuki T., et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 2012, 59:62-66.
16. Fujitsuka N., Asakawa A., Uezono Y., Minami K., Yamaguchi T., Niijima A., et al. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry 2011, 1:e23.
17. Imazu Y., Yanagi S., Miyoshi K., Tsubouchi H., Yamashita S., Matsumoto N., et al. Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation. Eur J Pharmacol 2011, 672:153-158.
18. Tsubouchi H., Yanagi S., Miura A., Iizuka S., Mogami S., Yamada C., et al. Rikkunshito ameliorates bleomycin-induced acute lung injury in a ghrelin-independent manner. Am J Physiol Lung Cell Mol Physiol 2014, 306:L233-L245.
19. Sato T., Kurokawa M., Nakashima Y., Ida T., Takahashi T., Fukue Y., et al. Ghrelin deficiency does not influence feeding performance. Regul Pept 2008, 145:7-11.
20. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 2004, 101:4679-4684.
21. Moore B.B., Hogaboam C.M. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008, 294:L152-L160.
22. Chambers A.P., Wilson-Perez H.E., McGrath S., Grayson B.E., Ryan K.K., D'Alessio D.A., et al. Effect of vertical sleeve gastrectomy on food selection and satiation in rats. Am J Physiol Endocrinol Metab 2012, 303:E1076-E1084.
23. Takeda H., Sadakane C., Hattori T., Katsurada T., Ohkawara T., Nagai K., et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008, 134:2004-2013.
24. Zhang G., Jin B., Li Y.P. C/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J 2011, 30:4323-4335.
25. Cao P., Hanai J., Tanksale P., Imamura S., Sukhatme V.P., Lecker S.H. Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J 2009, 23:2844-2854.
26. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
27. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999, 159:S1-S40.
28. Mendoza L., Gogali A., Shrikrishna D., Cavada G., Kemp S.V., Natanek S.A., et al. Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology 2014, 19:138-143.
29. Prescott E., Almdal T., Mikkelsen K.L., Tofteng C.L., Vestbo J., Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002, 20:539-544.
30. Marquis K., Debigare R., Lacasse Y., LeBlanc P., Jobin J., Carrier G., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:809-813.
31. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52:947-952.
32. Costelli P., Muscaritoli M., Bossola M., Penna F., Reffo P., Bonetto A., et al. IGF-1 is downregulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol 2006, 291:R674-R683.
33. Foletta V.C., White L.J., Larsen A.E., Leger B., Russell A.P. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch 2011, 461:325-335.
34. Sugiyama M., Yamaki A., Furuya M., Inomata N., Minamitake Y., Ohsuye K., et al. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Regul Pept 2012, 178:21-28.
35. Hattori T., Yakabi K., Takeda H. Cisplatin-induced anorexia and ghrelin. Vitam Horm 2013, 92:301-317.
36. Takeda H., Nakagawa K., Okubo N., Nishimura M., Muto S., Ohnishi S., et al. Pathophysiologic basis of anorexia: focus on the interaction between ghrelin dynamics and the serotonergic system. Biol Pharm Bull 2013, 36:1401-1405.
37. Yamada C., Saegusa Y., Nakagawa K., Ohnishi S., Muto S., Nahata M., et al. Rikkunshito, a Japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model. Biomed Res Int 2013, 2013:792940.
38. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
39. Mukai R., Horikawa H., Fujikura Y., Kawamura T., Nemoto H., Nikawa T., et al. Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice. PLoS One 2012, 7:e45048.